Randomized phase II trial of cytosine arabinoside with and without the CHK1 inhibitor MK-8776 in relapsed and refractory acute myeloid leukemia
Titel:
Randomized phase II trial of cytosine arabinoside with and without the CHK1 inhibitor MK-8776 in relapsed and refractory acute myeloid leukemia
Auteur:
Webster, Jonathan A. Tibes, Raoul Morris, Larry Blackford, Amanda L. Litzow, Mark Patnaik, Mrinal Rosner, Gary L. Gojo, Ivana Kinders, Robert Wang, Lihua Doyle, L. Austin Huntoon, Catherine J. Karnitz, Larry M. Kaufmann, Scott H. Karp, Judith E. Smith, B. Douglas